USC Roski Eye Institute

03/25/2026

Congratulations Dr. Kimberley Yu (PGY4) who has been selected as a recipient of the 2026 Bernard Schwarz Memorial Award by the American Glaucoma Society for the top resident abstract at the recent AGS Meeting.

Established in honor of Bernard Schwartz's enduring commitment to academic excellence and the advancement of medical education, this award is bestowed upon the resident whose submitted abstract achieves the highest distinction, this award recognizes exceptional scholarly achievement, intellectual rigor, and promise for future contributions to the field.

03/16/2026

AI meets eye care in USC medical student Ryan Shean’s research.

With support from Research to Prevent Blindness (RPB), Ryan seeks to enhance glaucoma diagnosis through investigations at the Keck School of Medicine of USC. Glaucoma diagnosis involves evaluating demographic factors, pressure within the eye, acuity of the vision, and structural and functional tests that reflect the health of the optic nerve. If the disease evades discovery, patients risk missing the chance for early therapies that help prevent vision from deteriorating. Together with Dr. Benjamin Xu, Ryan is testing whether large language models and generative AI chatbots can be part of the solution.

Link to full article in the comments.

03/05/2026

Some people find their calling. Rahul Dhodapkar found two, and built something remarkable with both.

After earning a degree in computer science from Yale University and working as an engineer at MongoDB, he returned to school, earned his MD, and is now an ophthalmology resident at USC. Today, he's channeling both worlds to build an AI-powered web app that automates the measurement of pediatric eye misalignment.

This February, he took that work to the national stage, presenting at the 2026 Association of University Professors of Ophthalmology (AUPO) Annual Meeting in San Diego.

Read our full Q&A to hear about his research, his journey, and what's next.

For USC ophthalmology resident Rahul Dhodapkar, medicine is a second career. He graduated from Yale University with a bachelor’s degree in computer science in 2015, and worked as an engineer at MongoDB, a large-scale database company. He later returned to Yale for medical school before arriving at...

02/26/2026

The latest Blue Ridge rankings for NIH funding in federal fiscal year 2025 are out, and we are excited to announce that we are #5 in National Institutes of Health (NIH) funding in our field, a reflection of our department's dedication to conducting exemplary research with direct impact on improving diagnostic evaluation and treatment of major eye diseases, including age-related and hereditary macular degeneration, dry eye, diabetic retinopathy, and glaucoma.

02/13/2026

Congratulations to Dr. Andrew Moshfeghi, who was selected as Top Doctors for 2026 by Castle Connolly Top Doctors. Castle Connolly Top Doctors represent the top 7% of all U.S. practicing physicians. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills.

02/04/2026

01/28/2026

“Where I am now is ‘give-back’ time,” the Half Century Trojan says.

01/21/2026

At USC Roski Eye Institute, oculofacial plastic surgery is a true team effort, blending expertise across several disciplines, which include dermatologists, otolaryngologists, general plastic surgeons, and even ocular oncologists.

Every year and a half, our residents and fellows have the opportunity to participate in our critically acclaimed USC Oculofacial Plastic Surgery Surgical Skills Course, which brings top minds together to train, learn, and innovate.

01/20/2026

In our mission to preserve, protect and restore sight, the vision researchers at the USC Roski Eye Institute play a critical role in driving fundamental and translational research to advance patient care. Ranked #4 in NIH research funding, the ophthalmology departments scientists and clinicians conduct exemplary research with direct impact on improving diagnostic evaluation and treatment of major eye diseases, including age-related and hereditary macular degeneration, dry eye, diabetic retinopathy, and glaucoma. The USC Roski Eye Institute has a rich and diverse research program that focuses on five research areas: Bioengineering and Nanotechnology, Epidemiology, Imaging, Inflammation and Regeneration, and Neurodegeneration.

01/06/2026

Shout out to Dr. Andrew Moshfeghi, medical director of the USC Roski Eye Institute and associate professor of clinical ophthalmology, who presented on Practical Tips for the Management of Patients with Geographic Atrophy at the Retina World Congress.

12/31/2025

In Ophthalmology Times, Dr. Mark Humayun discusses advance stem cell-derived therapies for dry age-related macular degeneration. Read more: https://www.ophthalmologytimes.com/view/mark-humayun-md-phd-discusses-advance-stem-cell-derived-therapies-for-dry-amd

12/23/2025

In Ophthalmology Times, Dr. Gloria Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy. Read more:

Chiu discusses factors affecting adoption of the FDA-approved epi-on therapy, from clinic setup to insurance coverage, while highlighting its safety and efficacy.